TABLE 1.
Assessment | Results | Reference range |
---|---|---|
Arterial blood gas (room air) | ||
pH | 7.004 | 7.35–7.45 |
pCO2, mmHg | 14.3 | 35–45 |
pO2, mmHg | 113.3 | 80–100 |
HCO3−, mmol/L | 3.5 | 22–26 |
Base excess, mmol/L | −25.9 | 0 ± 2 |
Anion gap, mmol/L | 35.5 | 10–14 |
Peripheral blood | ||
White blood cell/mm3 | 22,800 | 3300–8600 |
Red blood cell, ×104/mm3 | 387 | 386–492 |
Hemoglobin, g/dl | 11.7 | 11.6–14.8 |
Hematocrit, % | 40 | 35.1–44.4 |
Platelet, ×104/mm3 | 42.0 | 15.8–34.8 |
Biochemistry | ||
Blood urea nitrogen, mg/dl | 74.1 | 8–20 |
Creatinine, mg/dl | 2.97 | 0.65–1.09 |
Sodium, mmol/L | 120 | 135–145 |
Potassium, mmol/L | 6.9 | 3.6–4.8 |
Chlorine, mmol/L | 81 | 98–108 |
Plasma glucose, mg/dl | 1514 | 73–109 |
Hemoglobin A1c, % | 7.8 | 4.6–6.2 |
Fasting C‐peptide, ng/ml | <0.03 | 0.80–2.50 |
Glucagon‐stimulated C‐peptide, ng/ml | <0.03 | 0.80–2.50 |
β‐hydroxybutyrate, μmol/L | 13,555 | 0–76 |
Acetoacetate, μmol/L | 1669 | 13–69 |
Free T4, ng/ml | 1.13 | 0.90–1.70 |
Thyroid stimulating hormone, μ IU/ml | 3.33 | 0.50–5.00 |
Urine C‐peptide (μg/day) | <2.6 | 50–100 |
Immunological tests | ||
Anti‐GAD a antibody, U/ml | 44.8 | <5.0 |
Anti‐IA‐2 b antibody, U/ml | <0.6 | <0.6 |
Anti‐ZnT8 c antibody, U/ml | <10.0 | <10.0 |
Anti‐thyroglobulin antibody | 11.13 | <28 |
Anti‐thyroid peroxidase antibody | 10.81 | <16 |
HLA d ‐DNA typing | ||
DRB1*04:05:01/09:01:02 | ||
DQB1*03:03:02/04:01:01 |
GAD: glutamic acid decarboxylase.
IA‐2: insulinoma‐associated protein‐2.
ZnT8: zinc transporter 8.
HLA: human leukocyte antigen.